CIK 0000926617
- Non-accelerated filer
- Smaller reporting company
Aspira Women's Health Inc.
Sign in to watch- Ticker
- AWHL
- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330595156
- Phone
- +1 512-519-0400
- Business address
- 12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX, 78738
- Former names
- VERMILLION, INC., CIPHERGEN BIOSYSTEMS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 80 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2011-06-09 | Fung Eric T S.V.P & C.S.O | Purchase | +1,000 | $4.72 | $5K | 52,471 |
| 2011-03-22 | Fung Eric T SVP and Chief Science Officer | Grant or award | +41,000 | 51,471 | ||
| 2010-09-08 | Fung Eric T SVP, Chief Science Officer | Gift | −11,765 | 10,471 | ||
| 2010-08-24 | Fung Eric T SVP, Chief Science Officer | Grant or award | +20,169 | 22,236 | ||
| 2010-03-19 | Fung Eric T SVP & Chief Scientific Officer | Grant or award · Employee Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2008-11-03 | Fung Eric T VP-Chief Science Officer | Purchase | +250 | $0.43 | $106 | 2,260 |
| 2008-07-18 | Fung Eric T VP-Chief Science Officer | Grant or award · Stock Option (Right to buy) | +40,000 | 87,522 |
Page 1 of 1 · 7 trades